Zobrazeno 1 - 10
of 1 340
pro vyhledávání: '"Christopher P, Cannon"'
Autor:
Talia A. Loeb, Sarah M. Murray, Erin E. Cooney, Tonia Poteat, Keri N. Althoff, Christopher M. Cannon, Jason S. Schneider, Kenneth H. Mayer, J. Sonya Haw, Andrew J. Wawrzyniak, Asa E. Radix, Jowanna Malone, Dee Adams, Megan Stevenson, Sari L. Reisner, Andrea L. Wirtz, American Cohort to Study HIV Acquisition Among Transgender Women Study Group
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Transgender women (TW) experience significant inequities in healthcare access and health disparities compared to cisgender populations. Access to non-transition related healthcare is understudied among TW. We aimed to assess the a
Externí odkaz:
https://doaj.org/article/fbe4e115e5004be3af1e17a32d6a376f
Autor:
Erin E. Cooney, Haneefa T. Saleem, Meg Stevenson, Rodrigo A. Aguayo‐Romero, Keri N. Althoff, Tonia C. Poteat, S. Wilson Beckham, Dee Adams, Asa E. Radix, Andrew J. Wawrzyniak, Christopher M. Cannon, Jason S. Schneider, J. Sonya Haw, Allan E. Rodriguez, Kenneth H. Mayer, Chris Beyrer, Sari L. Reisner, Andrea L. Wirtz, American Cohort to Study HIV Acquisition Among Transgender Women (LITE) Study Group
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 12, Pp n/a-n/a (2023)
Abstract Introduction Transgender women in the United States experience high HIV incidence and suboptimal Pre‐exposure prophylaxis (PrEP) engagement. We sought to estimate PrEP initiation and discontinuation rates and characterize PrEP discontinuat
Externí odkaz:
https://doaj.org/article/fa02ebbcbdaa4843afa588221f570a45
Autor:
Tonia C. Poteat, PhD, PA-C, Ashleigh J. Rich, PhD, Huijun Jiang, MS, Andrea L. Wirtz, PhD, Asa Radix, MD, PhD, Sari L. Reisner, ScD, Alexander B. Harris, MPH, Christopher M. Cannon, MPH, Catherine R. Lesko, PhD, Mannat Malik, MHS, Jennifer Williams, PhD, Kenneth H. Mayer, MD, Carl G. Streed, Jr, MD
Publikováno v:
AJPM Focus, Vol 2, Iss 3, Pp 100096- (2023)
Introduction: Approximately 2% of the U.S. population identifies as transgender, and transgender people experience disproportionate rates of cardiovascular disease mortality. However, widely used cardiovascular disease risk estimators have not been v
Externí odkaz:
https://doaj.org/article/b2379be4840b463e8b3645dda5d00933
Autor:
Nishant P. Shah, Darren K. McGuire, Christopher P. Cannon, Robert P. Giugliano, Yuliya Lokhnygina, Courtney B. Page, Andrew M. Tershakovec, Eugene Braunwald, Michael A. Blazing
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 13 (2023)
Externí odkaz:
https://doaj.org/article/569161cd48b54a9b83b492bbf5595815
Autor:
Bernard Zinman, Bruce Neal, George L Bakris, Vlado Perkovic, Meg J Jardine, Kris Rogers, Jie Yu, Adeera Levin, Dick de Zeeuw, Hong Zhang, Kenneth W Mahaffey, Clare Arnott, Rajiv Agarwal, Gian Luca Di Tanna, Carol Pollock, David C Wheeler, Christopher P Cannon, David M Charytan, Hiddo J Lambers Heerspink, Norman Rosenthal
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 11, Iss 3 (2023)
Introduction Relationships between glycemic-lowering effects of sodium glucose co-transporter 2 inhibitors and impact on kidney and cardiovascular outcomes are uncertain.Research design and methods We analyzed 4395 individuals with prebaseline and po
Externí odkaz:
https://doaj.org/article/83663dfd99b5429482efb801e4aa82d8
Autor:
Simin Gharib Lee, Alexander J. Blood, Christopher P. Cannon, William J. Gordon, Hunter Nichols, David Zelle, Benjamin M. Scirica, Naomi D. L. Fisher
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 6 (2023)
Background The COVID‐19 pandemic disrupted traditional health care; one fallout was a drastic decrease in blood pressure (BP) assessment. We analyzed the pandemic's impact on our existing remote hypertension management program's effectiveness and a
Externí odkaz:
https://doaj.org/article/3569eac9372842309bd6f1c36593d45c
Get quick, portable access to the evidence you need to make effective clinical decisions! Evidence-Based Cardiology succinctly summarizes all the clinical trials that affect the practice of cardiovascular medicine, making it easy for you to implement
Autor:
Rodrigo A. Aguayo‐Romero, Christopher M. Cannon, Andrea L. Wirtz, Erin E. Cooney, Kenneth H. Mayer, Sari L. Reisner, the American Cohort to Study HIV Acquisition among Transgender Women (LITE) Study Group
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss S5, Pp n/a-n/a (2022)
Abstract Introduction Transgender women (TW) experience an increased risk of human immunodeficiency virus (HIV) acquisition. This study identified patterns of HIV awareness and prevention strategies used by TW who were not living with HIV. Methods Da
Externí odkaz:
https://doaj.org/article/15e0656bcf584fd0ae193d151a70143a
Autor:
Jennifer A. Rymer, Lisa A. Kaltenbach, Eric D. Peterson, David J. Cohen, Gregg C. Fonarow, Niteesh K. Choudhry, Timothy D. Henry, Christopher P. Cannon, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 20 (2022)
Background Persistence to P2Y12 inhibitors after myocardial infarction (MI) remains low. Out‐of‐pocket cost is cited as a factor affecting medication compliance. We examined whether a copayment intervention affected 1‐year persistence to P2Y12
Externí odkaz:
https://doaj.org/article/c2bc639b139b4b899c96f8eda4705648
Autor:
Jing‐Wei Li, Clare Arnott, Hiddo J. L. Heerspink, Qiang Li MBiostat, Christopher P. Cannon, David C. Wheeler, David M. Charytan, Jennifer Barraclough, Gemma A. Figtree, Rajiv Agarwal, George Bakris, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey, Vlado Perkovic, Bruce Neal, Meg J. Jardine
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 16 (2022)
Background The sodium‐glucose cotransporter 2 inhibitor canagliflozin reduced the risk of first cardiovascular composite events in the CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation) trial. In
Externí odkaz:
https://doaj.org/article/46cbfff7ef724eea8154c25524ea230a